Latest news
FMR LLC (DYN) discloses 6.8% Dyne Therapeutics stake in amended ownership filing - Stock TitanStock Titan · Thu, 06 Aug 2026 14:21:56 GMTDyne Therapeutics (DYN) Earnings Date and Reports 2026 $DYN - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMTAnalysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Dyne Therapeutics (DYN) - The Globe and MailThe Globe and Mail · Thu, 30 Jul 2026 07:00:00 GMTDyne Therapeutics reports Q2 net loss $178.6M, cash $898.5M; BLA for z-rostudirsen accepted with PDUFA Jan 21, 2027 - TradingViewTradingView · Wed, 29 Jul 2026 20:43:04 GMTDyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTDyne Therapeutics reports larger-than-expected Q2 net loss per share - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMTDyne Therapeutics (NASDAQ: DYN) details $299M loss, advances DMD and DM1 drugs - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMTDyne Therapeutics, Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMT